Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ADC, antiviral, arsenal, autoimmunity, automated, bispecific, BMS, CAGR, CIETAC, circumstance, Clawback, cohesive, conservatory, cornerstone, corroborative, crafted, datopotamab, DC, deactivate, deficiency, deployment, deruxtecan, digital, disaggregated, EDR, Eighteenth, email, Endocyte, epidemic, est, etoposide, EY, FDIC, flagging, Florham, FolateImmune, forefront, fostering, fraught, frontline, frozen, gemcitabine, Gongcheng, herewith, HHS, Hutchison, immunology, invaluable, IO, Israel, Jingtian, Labcorp, lawsuit, layer, Llyod, lockdown, Lu, LUNAR, Manhattan, manifest, Marcum, Mayo, micelle, mixed, multidisciplinary, multifactor, neurodegeneration, NJ, norm, optimum, Outlook, Park, PARP, pillar, Pluvicto, proactive, prompt, Purdue, reconciling, residential, revert, roughly, scanning, seized, sentinel, Seventeenth, SharePoint, Sixteenth, software, spearheaded, stance, struck, subdivision, swift, swiftly, thwart, tribunal, unaffiliated, uncompromising, unexercised, unilaterally, unpatentable, unrecorded, uphold, xi, Yingjuan
Removed:
accretion, AUD, BCF, bearer, collapse, Columbia, coordinating, curb, Czerepak, Daly, Daniel, degenerative, depolymerization, Elizabeth, England, fellowship, fluid, founded, fungal, Gordon, Han, Hutch, inducement, inhibiting, iron, Kun, McGill, Mendel, Mine, mitochondrial, negotiable, NY, partnering, prospectively, Qualitative, renamed, renewal, republished, resignation, Richard, Schooley, Shanxi, SIMBA, skin, stabilize, subscription, Taiyuan, Toronto, toxicology, Triphase, ultimate, Unresolved, upheld, vascular, Verne, wife, Zabrowski
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.2 Exhibit 2.2
- 4.4 Exhibit 4.4
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 4.23 Exhibit 4.23
- 4.27 Exhibit 4.27
- 4.28 Exhibit 4.28
- 8.1 Exhibit 8.1
- 12.1 Exhibit 12.1
- 13.1 Exhibit 13.1
- 15.1 Exhibit 15.1
- 15.2 Exhibit 15.2
- 15.3 Exhibit 15.3
- 15.4 Exhibit 15.4
- 16.1 Exhibit 16.1
- 97.1 Exhibit 97.1
BYSI similar filings
Filing view
External links
Exhibit 16.1
Letter from Ernst & Young Hua Ming LLP
to the Securities and Exchange Commission
April 29, 2024
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read Item 16F of Form 20-F dated April 29, 2024 of BeyondSpring Inc. and are in agreement with the statements contained in the first to third paragraphs on page 168 therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
/s/ Ernst & Young Hua Ming LLP
Beijing, the People’s Republic of China